Skip to main content
Alfredo Iacoangeli

Dr Alfredo Iacoangeli

Reader in Bioinformatics

Biography

After a career in Biophysics, Dr. Alfredo Iacoangeli accepted his PhD "cum laude" in Life Sciences in January 2016 from Sapienza University of Rome where he worked in the field of structural bioinformatics with a particular focus on protein structure prediction and protein-peptide interaction, Alfredo joined King’s College London in March 2016, and is now the lead of a joint programme between the Department of Basic and Clinical Neuroscience and the Health Informatics Unit at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London.

The aim of this programme is twofold:

1) the development of computational approaches based on statistical, machine learning and bioinformatics methods, to study the biological basis of neurodegenerative diseases;

2) the use of large multi-omics and clinical datasets to identify subgroups of patients affected by neurodegenerative diseases with homogeneous disease causes and clinical phenotype, that can be used for precision approaches to clinical and biomedical research.

Dr Iacoangeli is first author of several scientific articles in the field of Structural and Genomic Bioinformatics, machine learning and MND/ALS genetics. 

He is the Deputy Lead of the Motor Neuron Disease research theme at the NIHR Maudsley Biomedical Research Centre.

 

Research Interests: 

  • Bioinformatics
  • Machine learning
  • Genomics
  • Motor Neurone Disease
  • Neurodegeneration

Teaching:

  • Bioinformatics, interpretation and data quality assurance in genome analysis 
  • Advanced Bioinformatics
  • Practical Structural Bioinformatics

Expertise and Public Engagement:

News

Dr Alfredo Iacoangeli receives the 2024 Paolo Gontijo Award

Dr Alfredo Iacoangeli was awarded the Paulo Gontijo award at the 35th International Symposium on ALS/MND on 6 December 2024 in Montreal, Canada.

A group of five people - two women on the left and three men on the right, with Dr Alfredo Iacoangeli in the centre. They are all wearing white lanyards with MNDA symposium branded banners behind them

King's researcher receives nearly £1 million to investigate the role of ancient viral DNA in ALS

Dr Alfredo Iacoangeli has been awarded £983,708 funding from the Medical Research Council (MRC) to explore how genetic sequences acquired millions of years...

iStock-637808526

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government

The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

20240613 Perronvisit

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

Dr Alfredo Iacoangeli receives Genes 2022 Young Investigator Award in Human Genomics and Genetic Diseases

Dr Alfredo Iacoangeli was recognised by the journal, Genes, for his contributions to the fields of human genomics and genetic diseases.

Alfredo Iacoangeli

News

Dr Alfredo Iacoangeli receives the 2024 Paolo Gontijo Award

Dr Alfredo Iacoangeli was awarded the Paulo Gontijo award at the 35th International Symposium on ALS/MND on 6 December 2024 in Montreal, Canada.

A group of five people - two women on the left and three men on the right, with Dr Alfredo Iacoangeli in the centre. They are all wearing white lanyards with MNDA symposium branded banners behind them

King's researcher receives nearly £1 million to investigate the role of ancient viral DNA in ALS

Dr Alfredo Iacoangeli has been awarded £983,708 funding from the Medical Research Council (MRC) to explore how genetic sequences acquired millions of years...

iStock-637808526

Over £1.4 million awarded to King's researchers to accelerate MND treatment development

Three projects led by researchers at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have received MND Translational Accelerator awards...

MND Accelerator awards 2024

King's Motor Neurone Disease Care and Research Centre Hosts Delegation from Perron Institute and Western Australian Government

The esteemed guests included Steve Arnott, CEO of Perron Institute, and John Langoulant, Agent General for Western Australia.

20240613 Perronvisit

King's College London and LifeArc team up to accelerate MND treatment development

LifeArc has pledged £1.5 million to fund a new two-year collaborative partnership with King’s College London.

Molecules MND

Dr Alfredo Iacoangeli receives Genes 2022 Young Investigator Award in Human Genomics and Genetic Diseases

Dr Alfredo Iacoangeli was recognised by the journal, Genes, for his contributions to the fields of human genomics and genetic diseases.

Alfredo Iacoangeli